Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Mengzhu Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4488-8008; OpenAlex author ID A5058321300. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape. Co-author DOI 10.7150/ijbs.131102↗
  2. Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming. First author DOI 10.1007/s00109-022-02181-8↗
  3. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH. Co-author DOI 10.1039/c9fo00394k↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingyan Ding · 1 shared paper, 2026 · strength 0.30
  2. Senlin Li · 1 shared paper, 2026 · strength 0.30
  3. Cheng Tian · 1 shared paper, 2026 · strength 0.30
  4. Ming Xiang · 1 shared paper, 2026 · strength 0.30
  5. Hua Li · 2 shared papers, 2019–2022 · strength 0.27
  6. Lixia Chen · 2 shared papers, 2019–2022 · strength 0.27
  7. Yueying Yang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.